Is lowering phosphate exposure the key to preventing arterial stiffening with age?

Heart

Volumn 95, Issue 21, 2009, Pages 1770-1772

  Ferro, C J ^a   Chue, C D ^b   Steeds, R P ^a   Townend, J N ^a  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATE; PROTEIN;

AGING; ARTERIAL STIFFNESS; ARTERIOSCLEROSIS; ARTERY CALCIFICATION; ATHEROMA; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHRONIC KIDNEY DISEASE; DIET; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; KIDNEY FUNCTION; MORBIDITY; MORTALITY; PHOSPHATE BLOOD LEVEL; PHOSPHATE INTAKE; POPULATION; PRIORITY JOURNAL; RIGIDITY; SHORT SURVEY; SYSTOLIC HYPERTENSION;

AGE FACTORS; ARTERIOSCLEROSIS; CALCINOSIS; CARDIOVASCULAR DISEASES; DIET; HUMANS; KIDNEY FAILURE, CHRONIC; PHOSPHATES; RISK FACTORS; VASOCONSTRICTION;

EID: 70350244426     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2008.162594     Document Type: Short Survey

References (30)

1. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 1997;349:1269-1276 (Pubitemid 27192468)
2. Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 2006;27:2588-2605 (Pubitemid 44627304)
3. Davies JE, Parker KH, Francis DP, et al. What is the role of the aorta in directing coronary blood flow? Heart 2008;94:1545-1547
4. Wang JJ, O'Brien AB, Shrive NG, et al. Time-domain representation of ventricular-arterial coupling as a windkessel and wave system. Am J Physiol Heart Circ Physiol 2003;284:H1358-68.
5. Laurent S, Boutouyrie P. Recent advances in arterial stiffness and wave reflection in human hypertension. Hypertension 2007;49:1202-1206 (Pubitemid 46809353)
6. He J, Klag MJ, Whelton PK, et al. Migration, blood pressure pattern, and hypertension: the Yi Migrant Study. Am J Epidemiol 1991;134:1085-1101
7. Calvo MS, Park YK. Changing phosphorus content of the U.S. diet: potential for adverse effects on bone. J Nutr 1996;126:1168S-80S.
8. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA 2007;298:2038-2047 (Pubitemid 350074801)
9. Edwards NC, Ferro CJ, Townend JN, et al. Aortic distensibility and arterial-ventricular coupling in early chronic kidney disease: a pattern resembling heart failure with preserved ejection fraction. Heart 2008;94:1038-1043
10. Moe SM, Drueke T, Lameire N, et al. Chronic kidney disease-mineral-bone disorder: a new paradigm. Adv Chronic Kidney Dis 2007;14:3-12. (Pubitemid 46014534)
11. Block GA, Klassen PS, Lazarus JM, et al. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004;15:2208-2218 (Pubitemid 39031360)
12. Dhingra R, Sullivan LM, Fox CS, et al. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 2007;167:879-885 (Pubitemid 46762749)
13. Tonelli M, Sacks F, Pfeffer M, et al. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 2005;112:2627-2633 (Pubitemid 41532599)
14. Raggi P, Giachelli C, Bellasi A. Interaction of vascular and bone disease in patients with normal renal function and patients undergoing dialysis. Nat Clin Pract Cardiovasc Med 2007;4:26-33. (Pubitemid 44971069)
15. Moe SM, Chen NX. Mechanisms of vascular calcification in chronic kidney disease. J Am Soc Nephrol 2008;19:213-216 (Pubitemid 351240642)
16. Rodriguez M, Felsenfeld AJ. PTH, FGF-23 and early CKD. Nephrol Dial Transplant 2008;23:3391-3393
17. Covic A, Kothawala P, Bernal M, et al. Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease. Nephrol Dial Transplant 2009;24:1506-1523
18. Reynolds JL, Joannides AJ, Skepper JN, et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 2004;15:2857-2867
19. Watson KE, Abrolat ML, Malone LL, et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 1997;96:1755-1760
20. Zittermann A, Schleithoff SS, Tenderich G, et al. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol 2003;41:105-112
21. Weber KT, Simpson RU, Carbone LD. Vitamin D and calcium dyshomoeostasis-associated heart failure. Heart 2008;94:540-541
22. Li YC, Kong J, Wei M, et al. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002;110:229-238
23. Xiang W, Kong J, Chen S, et al. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am J Physiol Endocrinol Metab 2005;288:E125-32. (Pubitemid 40023798)
24. Smith JC, Page MD, John R, et al. Augmentation of central arterial pressure in mild primary hyperparathyroidism. J Clin Endocrinol Metab 2000;85:3515-3519 (Pubitemid 30828544)
25. Amann K, Ritz E, Wiest G, et al. A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia. J Am Soc Nephrol 1994;4:1814-1819 (Pubitemid 24976985)
26. Rostand SG, Drueke TB. Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int 1999;56:383-392 (Pubitemid 29353135)
27. Kosch M, Hausberg M, Vormbrock K, et al. Impaired flow-mediated vasodilation of the brachial artery in patients with primary hyperparathyroidism improves after parathyroidectomy. Cardiovasc Res 2000;47:813-818 (Pubitemid 30676295)
28. Takenaka T, Suzuki H. New strategy to attenuate pulse wave velocity in haemodialysis patients. Nephrol Dial Transplant 2005;20:811-816 (Pubitemid 40520661)
29. Flegal KM. Evaluating epidemiologic evidence of the effects of food and nutrient exposures. Am J Clin Nutr 1999;69:1339S-44S.
30. Berns JS. Niacin and related compounds for treating hyperphosphatemia in dialysis patients. Semin Dial 2008;21:203-205